I N T RODUCT ION
Toxoplasma gondii is an obligate intracellular parasite in the family Apicomplexa (for an excellent collection of recent reviews, see the book by Gross (1996) ). It is one of the most common parasites of animals, being found worldwide in a large range of warm-blooded verterbrates and at a very high prevalence. In France, for example, T. gondii infection is detectable in up to 85% of otherwise healthy adults (Desmonts & Couvreur 1974) . The initial infection is characterized by a disease of variable severity but typically giving in£uenza-like symptoms and lymphadenopathy (Luft & Remington 1992) . How the disease progresses depends largely on the immune status of the individual infected. Traditionally, this parasite had been well known as a cause of severe foetal infection in cases where a mother acquires her ¢rst infection during pregnancy. More recently, however, it has also emerged as an important opportunistic pathogen of immunocompromised persons, especially AIDS patients, in whom a potentially fatal pneumonia and toxoplasmic encephalitis can ensue.
The parasite has many natural properties that have attracted a growing number of investigators to its study. Immunologists have been attracted by the e¤-cient immune response it elicits, which yields protection against signi¢cant disease except in the two scenarios given above. Cell biologists have been attracted by its elegant ultrastructure, which includes a number of organelles dedicated to the intracellular lifestyle (i.e. attachment, invasion and intracellular growth and egress). More recently, developmental biologists have become interested in this protozoan because, as with many parasites, T. gondii has a complex life cycle, which includes a number of discrete developmental stages. In ¢gure 1, the life cycle is depicted in a somewhat unconventional way as consisting of two potentially independent cycles, one asexual and one sexual. This emphasizes that the parasite appears fully capable of propagating itself in nature through either cycle. Indeed, recent evidence suggests that di¡erent strains rely on the two cycles to di¡erent degrees and, in the virulent lines such as RH, perhaps only the asexual mode is used Darde et al. 1992) . In practical terms, this uncertainty means that it is not clear what fraction of human infection is a result of ingesting meat containing tissue cysts (arrow 3) rather than a result of accidental ingestion of oocysts (arrow 7).
The sexual cycle is a classical coccidian one and involves gametogenesis, zygote formation and development into an oocyst that is shed in the faeces of the cat (the only known animal in which the sexual cycle can occur). Following a short time in the environment (ca. 2 d), the oocyst matures and becomes fully infectious. In terms of genetics, this sexual cycle shows classical mendelian properties as described in detail in Pfe¡er-korn & Pfe¡erkorn (1980) . The asexual cycle, which can occur in almost any warm-blooded animal, is simpler. It consists of two stages, the rapidly dividing tachyzoite (Greek tachy, fast) and the more slowly growing, encysted bradyzoite (brady, slow). In an infected animal there is an equilibrium between these two stages so that early in the infection tachyzoites predominate but as the host's immune response engages the parasite there is a shift toward the encysted bradyzoite. Both forms are capable of appearing in almost any tissue in the animal.
. M AT E R I A L S A N D M ET HOD S
Except as noted below, all materials and methods used standard reagents and protocols as recommended by the supplier and/or generally available laboratory manuals (see, for example, Harlow & Lane 1988; Ausubel et al. 1996) .
(a) Parasite strain
As with any project where mutants are to be studied, the choice of parental strain is critical to be sure that the desired phenotype can be obtained and further studied. For this study, a recently cloned derivative of the ME49 strain of T. gondii, which has become thè workhorse' of many laboratories interested in bradyzoite development (the origin of this strain is described by Boothroyd et al. 1995) . Detailed restriction fragment length polymorphism (RFLP) analysis of ME49 and a cloned derivative therefrom showed no di¡erences; this result suggested that the ME49 strain was already e¡ectively clonal at the time when the subclones were derived ). This is not surprising given that the strain was originally isolated from a piece of infected lamb, which was unlikely to have carried a large number of tissue cysts, and that it has been passed extensively in animals since then.
The clone used for the bulk of the work described in this paper has been designated PDS and was generated from ME49 oocysts produced by Elmer Pfe¡erkorn. Note that the derivative was cloned out of oocysts to ensure that the line would be fully competent for all stages of the life cycle. This is especially important should a cross in cats ever be attempted: the ability to productively infect these animals (i.e. to produce oocysts) can be lost after continuous passage as tachyzoites (E. R. Pfe¡erkorn, personal communication). Thus, low-passage-number cultures were used for all mutant and genetic analyses.
The advantages of the ME49 (PDS) strain are as follows.
1. It is a representative of one of the most commonly seen genotypes in infected people Darde et al. 1992; Howe & Sibley 1995) .
2. It is not highly virulent, and thus meaningful measurements of changes in LD 50 , for example, can be obtained (compared with RH, which has an LD 50 in mice of less than 10).
3. It grows su¤ciently well in vitro to be able to prepare reasonable amounts of material.
4. It readily di¡erentiates to bradyzoites in vitro under appropriate stimuli (see below).
5. It is readily transfected . 6. There are many reagents available for this strain, including a genetic map , cDNA and genomic DNA libraries, and specially engineered strains and mutants (e.g. those with atovaquone resistance (Tomavo & Boothroyd 1995) or those that are hypoxanthine/xanthine/guanine phosphoribosyl-transferase (HXGPRT)-de¢cient (Donald et al. 1996) ).
(b) Protocol for di¡erentiation of tachyzoites to bradyzoites in vitro
To induce tachyzoites to di¡erentiate to bradyzoites in vitro, the high-pH method of Soete et al. (1993) was chosen. This method has the advantage of being cheap, simple, and easily monitored (through pH indicators). It has also proven the most e¤cient.
The protocol is as follows. A con£uent monolayer of human foreskin ¢broblasts (HFF) is infected with tachyzoites from a recently lysed culture at a multiplicity of infection of ca. 0.1. These are allowed to grow in standard tachyzoite conditions for four hours (i.e. in Dulbecco's modi¢ed Eagle's medium (DMEM) with 10% Nu-serum at pH 7.2, under 5% CO 2 ) to allow invasion and initial growth. After this, the medium is removed and replaced with inducing medium (RPMI/ HEPES, pH 8.1, 5% fetal bovine serum) and the culture placed in a 37 8C air incubator. The inducing medium is replaced every 2 d. In longer incubations, the pH can vary and is readjusted by regulating exposure to air and/or by adding 1^2 drops of base (NaOH). By about 2 d, the vacuoles show distinct signs of Figure 1 . The life cycle of T. gondii. The asexual cycle can occur in a large number of warm-blooded animals and is shown on the left. It involves an equilibrium between the rapidly dividing tachyzoite and the more slowly dividing bradyzoite (arrows 1 and 2). The balance in this equilibrium is believed to be determined by environmental factors, especially stress provided by the host's immune response; encystment results from a strong immune response whereas reactivation occurs when the pressure is relaxed. To what degree the process is inductive, rather than selective, is not yet clear. Transmission through the asexual cycle is by ingestion of (undercooked) meat and other organs containing the infectious, encysted bradyzoites (arrow 3; e.g. rat to pig, or, pig to human). Scavenging allows the parasite to cycle through the food chain (e.g. pig to rat). The sexual cycle is shown on the right and involves schizogony, gametogenesis and fertilization (arrow 4) in the gut epithelium of felines. Cat-to-cat transmission through the sexual cycle is by ingestion of oocysts in faecal contamination (arrow 5). Crossover between the two cycles is represented by arrows 6 and 7 but, as mentioned in the text, the relative extent of this in nature is not known for all strains.
becoming cysts (rounding up and showing stacked parasites, compared with the £attened rosettes of the tachyzoite vacuoles) and parasite division is reduced. By about 6 d, clear cyst-like structures are apparent, containing 50^100 parasites.
R E SU LT S
A number of approaches to studying the developmental biology of T. gondii have been taken, focusing on biochemical, genetic and molecular genetic strategies. As yet, attention has been restricted to the asexual development (tachy^brady switch) for simple logistical reasons: the sexual cycle occurs only in cats and has not yet been reproduced in culture.
(a) The tissue-cyst wall contains GlcNAc, probably in chitin
In recent years, a number of groups have found conditions that cause tachyzoites growing in vitro to di¡erentiate into bradyzoites (Soete et al. 1993; Bohne et al. 1993 Bohne et al. , 1994 Weiss et al. 1995) . Although these may not be identical to fully`mature' bradyzoites found in vivo, they are unquestionably well along the pathway leading to mature cysts. This conclusion is based on the facts that (a) they show strong expression of several genes whose expression is normally absolutely restricted to bradyzoites, and (b) they are resistant to pepsin digestion in acid, a biologically relevant hallmark of the natural cyst (this property allows survival through the stomach and release in the gut). Under the high-pH conditions developed by Soete et al. (1993) , the ability of the cysts to bind a number of lectins in vitro was tested. Of the twelve tested, only two, Dolichos bi£orus seed lectin and succinylated wheat-germ agglutinin (S-WGA), showed speci¢c binding (¢gure 2). This was con¢rmed by speci¢c inhibition of binding with their sugar haptens, N-acetylgalactosamine (GalNAc) and N-acetylglucosamine (GlcNAc), respectively.
To directly assess the nature of the S-WGA-binding material and because the (b-1,4-linked polymer of GlcNAc (chitin) serves as the major cell-wall component in other systems such as yeast, in vitro-derived cysts were treated with chitinase; their ability to bind S-WGA was then assessed. The result was a loss in S-WGA binding and a disruption in the cyst wall, leading to release of some of the bradyzoites within. These results suggest that chitin may represent a significant part of the cyst wall composition.
(b) Expressed sequence tags from bradyzoites in vitro
One way to gain some idea of the di¡erences in gene expression in two developmental forms is to look at the di¡erences in their mRNA expression. This can be done in a number of ways, including di¡erential display (Liang & Pardee 1992) . In the present study, e¡orts and projects were combined to generate a large number of expressed sequence tags (ESTs) from the tachyzoite and bradyzoite stages. Although it is not particularly elegant, this strategy has the advantage that stage-speci¢c ESTs can be gleaned from a scan of the database and any promising candidates are easy to pursue because a partial sequence and cDNA clone are available. Additionally, the choice of which to pursue can be made with some knowledge of probable coding function. A cDNA library has been generated from the ME49 strain (PDS clone), starting with either in vitro tachyzoites or in vitro bradyzoite mRNA. The latter material was from cultures infected with tachyzoites but then switched to high pH, as described above. In this case, the parasites were harvested 6 d after inducing the switch, by which time they are expressing many bradyzoite-speci¢c markers, including the cyst wall. The hope is that this population includes parasites that are at di¡erent stages in the switching pathway and thus the ESTs that will be obtained will include genes that are turned on early and late in the process. Sequencing of the tachyzoite library has been completed (Ajioka et al. 1998) . This augments another completed e¡ort on cDNA from tachyzoites of the RH strain (Wan et al. 1996; Ajioka et al. 1998 Figure 2 . The tissue-cyst wall contains GlcNAc, probably in chitin. In vitro tissue cysts were generated by growth in medium at pH 8.1 and then stained with (biotinylated) succinylated wheat-germ agglutinin (a). Detection was with streptavidin conjugated to texas red. (b) A phase micrograph of the same ¢eld. Note that the lectin staining is speci¢c to the cyst wall and not to the free parasites.
Cambridge group (http://www.ebi.ac.uk/parasites/toxo/toxpage.html).
(c) Genetic mapping of a bradyzoite-speci¢c gene, P36
Another way to examine the di¡erentiation process is to exploit the ability to perform genetic crosses with this parasite and map natural (or selected) variants in the process. It had previously been noted that the CEP strain did not show expression of a bradyzoite-speci¢c surface antigen (P36) when exposed to switching conditions, at least as judged by Western blot analysis and immuno£uorescence assay with a monoclonal antibody (mAb) for this protein (Tg4A12) (Tomavo et al. 1991) . To map this polymorphism, we examined the previously characterized progeny of a cross between the CEP and ME49 strains for reactivity with this monoclonal antibody. Figure 3(a) shows a Western blot in which lysates from 11 of the F 1 progeny of this cross are probed with the anti-P36 mAb. When this was compared with the previously determined segregation pattern for over 60 RFLP markers , there was perfect cosegregation of the P36 reactivity and the c20A RFLP marker in all 19 strains examined, indicating tight linkage (¢gure 3b). Figure  3(c) shows the map position indicated by this result.
The basis for this polymorphism is currently under investigation. It could result from a di¡erence in the P36 structure such that the epitope seen by the mAb is not present in the CEP allele. Alternatively, it could indicate the total absence of the P36 protein from the CEP strain or a failure to turn on bradyzoite-speci¢c genes in response to the high-pH conditions. Use of other bradyzoite-speci¢c antibodies will help to resolve this issue.
(d) Complementation protocols
Regardless of the nature of the P36 polymorphism, it should be possible to complement the CEP strain with a library from ME49 (i.e. to restore anti-P36 reactivity). Currently, there are a large number of techniques available for high-e¤ciency transformation of Toxoplasma (reviewed in Roos et al. 1994; Boothroyd et al. 1995) . Although these could allow the simple complementation envisaged here, an episomal vector potentially has several other advantages, including even higher e¤-ciency and making recovery of the complementing gene trivial. A genomic sequence of 500 bp that confers replicative stability on a pBluescript backbone has been selected. The resulting plasmid has been used for constuction of a genomic library and this has successfully been used to complement an Hpt 7 mutant, yielding the wild-type HPT gene in the recovered episome, as expected. A similar library will be used to complement the CEP strain for anti-P36-reactivity. It will also be used for complementation of the di¡erentiation mutants whose generation is described below.
(e) Use of an engineered NTPase for negative selection
As with the natural`mutant' just described (i.e. the CEP strain), it should be possible to identify genes critical for the di¡erentiation process by generating mutants in the laboratory. To do this, a strategy is needed that will select for di¡erentiation mutants over the wild type. The approach in the present study has been to introduce a negative selectable marker under control of a bradyzoite-speci¢c promoter such that when wild-type parasites switch from tachyzoite to bradyzoites, they will die. Upon mutagenesis (e.g. with ethyl nitrosourea) it should then be possible to select for mutants that are unable to switch.
Two negative selectable markers have been chosen: hypoxanthine^xanthine^guanine phosphoribosyl transferase (HPT (Donald et al. 1996) ; see below) and an engineered form of the potent Toxoplasma nucleotidase (NTPase (Asai et al. 1983 (Asai et al. , 1995 Bermudes et al. 1994) ). This latter enzyme is normally synthesized as a secreted protein, which is stored in the dense granules before release. Upon invasion into a host cell, the contents of the dense granules are delivered into the developing parasitophorous vacuole where the NTPase serves to convert host NTPs (which di¡use into the vacuole through pores) into NMPs that are presumably acted on by a phosphatase to produce nucleosides for uptake . The strategy in this study has been to engineer the NTPase gene (speci¢cally NTP2 by Asai's nomenclature) such that it lacks the region encoding the N-terminal signal peptide that normally serves to target the NTPase to the secretory pathway and then place this under control of a bradyzoite-speci¢c promoter. The expectation is that, on di¡erentiation to the bradyzoite form, such an enzyme will be synthesized and retained within the cytosol, where it will prove highly toxic because it will degrade the parasite's own NTP stores. This cytosolic form of the enzyme is termed cNTP.
To test this concept, a plasmid with the LDH2 gene, including £anking sequence, was obtained from Dr S. Parmley (Palo Alto Medical Foundation). This gene was isolated in a screen for bradyzoite-speci¢c cDNAs and encodes a form of lactate dehyrogenase apparently found only in bradyzoites, as no mRNA for this gene is detectable in tachyzoites (Yang & Parmley 1995) . The region extending from ca. 720 bp upstream of the transcription start site (as mapped by Dr Parmley) through to the start codon, ca. 270 bp downstream of this site (F. Seeber, S. Parmley and J.C.B., unpublished data), has been subcloned. This was placed upstream of a form of the NTP2 gene lacking the signal peptide (generated by polymerase chain reaction (PCR)). Downstream of this coding region, ca. 1750 bp of 3'-LDH2 gene sequence was inserted.
The resulting construct (LDH2^cNTP2) (¢gure 4) was cotransfected into wild-type PDS parasites along with the cat selectable marker and chloramphenicol selection was applied (Kim et al. 1993) . As a control, parasites were transfected with a constitutively expressing version (under control of the TUB1 promoter ). The results are summarized in table 1. They show that 20% of the parasites transfected with the cat and LDH2^cNTP2 constructs and selected for chloramphenicol resistance had both plasmids whereas parallel experiments with cat and the TUB1^cNTP2 yielded no cotransfectants. Thus, LDH2^cNTP2 can be tolerated in tachyzoites although some integration events may have led to loss of regulation and subsequent toxicity in the tachyzoites. The constitutively expressing TUB1^cNTP2 plasmid appears to be highly deleterious to tachyzoites, as expected: no cotransfectants were obtained.
Next, the e¡ect of switching the parasites to bradyzoites in vitro was examined for one of the parasites successfully transfected with the LDH2^cNTP2 construct. The results (table 1) showed that LDH2ĉ NTP2 is indeed turned on and toxic in the bradyzoites: the parasite vacuoles swelled and growth generally stopped at the 2^4-cell stage with no further cyst development. When the cultures were treated with pepsin to digest the cyst (Freyre 1995) and tachyzoite cultures were initiated, no parasites were recovered. Parasites with only the cat construct di¡erentiated e¤ciently and were fully viable after pepsin digestion and recovery as tachyzoites. This strategy is now being further re¢ned by using the episomal vector described in the previous section. Ultimately, it should allow for generation of mutants that are de¢cient in their ability to di¡er-entiate to the bradyzoite stage in response to the highpH conditions.
(f) Promoter trap with HPT
A second selectable marker, HPT, which has the major advantage of being usable in both positive and negative selection strategies, has also been pursued. Expression of HPT in the presence of 6-thioxanthine (6-TX) is growth-inhibitory to the parasite: HPT converts the 6-TX to 6-thioxanthineribose monophosphate, which can inhibit guanosine monophosphate (GMP) synthetase and/or be further phosphorylated and then misincorporated into RNA. Conversely, growth in the presence of mycophenolic acid (MPA) and xanthine will select for the presence of HPT, because MPA will inhibit the only alternative route to xanthosine monophosphate (XMP) (inosine monophosphate (IMP) dehydrogenase), making the parasites fully dependent on HPT for growth. The use of this selection strategy was developed for Toxoplasma by Drs E. Pfe¡erkorn, B. Ullman, D. Roos and colleagues (Donald et al. 1996) ; protocols and reagents were kindly provided to us by Dr Roos and/or obtained from the O¤ce of AIDS Research Repository.
The selection strategy requires starting with a strain of parasite that is de¢cient in HPT. To create such a strain, Dr Roos' laboratory used a cloned derivative of wild-type ME49 (inthis case PLK) and inactivated the endogenous HPT gene by targeted insertional mutagenesis. Such a strain has been found to be completely resistant to up to 400 mg ml 71 6-TX (over this concentration the host cells begin to be a¡ected). Growth of wild-type PLK, in contrast, is completly eliminated by concentrations as low as 40 mg ml 71 6-TX. Once this Hpt 7 strain had been obtained, it was necessary to engineer it such that it carried the HPT gene under control of a bradyzoite-speci¢c promoter. To do this, a promoterless copy of the HPT gene was inserted into a plasmid to yield the construct shown in ¢gure 5(a). This HPT cassette includes 30 bp of bu¡er sequence (with no start or stop codons) upstream of the HPTcoding region so that if any chew-back occurs on integration the HPT will not be a¡ected. The resulting plasmid was linearized immediately upstream of this cassette and electroporated into the Hpt 7 PLK strain by using restriction-enzyme-mediated integration (REMI) ). It was found that REMI gave a considerable enhancement of stable transformation frequency in Toxoplasma. In this particular experiment, DpnII was used as the added enzyme; DpnII will not digest the bacterially grown plasmid but will damage the parasite DNA and thus induce the repair machinery that is thought to mediate the integration.
Stable transformants were selected for chloramphenicol resistance (Kim et al. 1993) . Because an attempt was being made to select bradyzoite-speci¢c genes, the resulting population was grown as tachyzoites in the presence of either 40 or 400 mg ml 71 6-TX to select for parasites with variable HPT expression. Both concentrations will stop the growth of all parasites that have the promoterless HPT integrated downstream of a promoter that is on in tachyzoites. The population that survived this treatment was then induced to di¡er-entiate to bradyzoites and subjected to a positive selection by growing the parasites in medium containing 50 mg ml 71 xanthine (X) as a substrate for HPT and either 100 or 200 mg ml 71 MPA. In this way, parasites that have turned on the HPTgene will survive whereas those that had the plasmid integrated into transcriptionally silent regions (or inserted in any way that did not give active expression) will die.
Several lines have been generated by using this or simlar protocols. The growth of one of these strains under bradyzoite conditions was virtually una¡ected by the presence of 200 mg ml 71 MPA+X. For convenience, this line will be referred to as the BH1 line (for bradyzoite control of HPT expression). Most critically, the killing of BH1 when grown as bradyzoites in the presence of 6-TX was examined. To do this, duplicate cultures were infected with 7610 5 tachyzoites of the parental (Hpt 7 ) or BH1 lines. The medium was changed after 4 h to bradyzoite-inducing conditions and incubation was continued at 37 8C in air. Approximately 14 h after this, 6-TX was added to one of each pair of £asks to a concentration of 300 mg ml 71 and incubation was continued for another 32 h. The parasites were harvested and syringed and dilutions were used to infect fresh monolayers under tachyzoite-culturing conditions, again in the presence or absence of the drug, and incubated at 37 8C in 5% CO 2 . Fourteen hours after reinfection, the medium (without 6-TX) was replaced in all £asks. The £asks were incubated for 7 d, after which plaque numbers were determined by standard methods. The results showed that BH1 had only about 4% parasite survival, compared with growth in the absence of drug. The parental control, on the other hand, showed the expected ca. 95% survival. Further examination of BH1, however, showed that it was also expresed at the tachyzoite stage, albeit minimally; it is therefore not strictly a bradyzoite-speci¢c gene. By increasing the stringency of the 6-TX and/or the incubation times, it has been possible to remove constitutive expressers from the pool of mutants and select genes whose expression appears to be restricted to the bradyzoite stage. These new strains are currently being tested for ability to survive 6-TX in bradyzoite conditions. These should ultimately provide the necessary genetic background to allow the selection of mutants based on an inability to respond to the stimuli for di¡erentiation in vitro and thereby survive treatment with 6-TX. Work is now in progress to select such mutants and identify the genes that may be crucial to the di¡erentiation process.
. C ONC LU S ION S
A major e¡ort to understand the intricate biology and biochemistry of development in T. gondii has begun. Thanks to the e¡orts of many laboratories over the past ¢ve years or so, many of the tools and reagents essential to this undertaking are now available. In the coming ¢ve years, we can look forward to major advances in the understanding of the developmental biology of this important parasite. Translating these to the bene¢t of the animals and people a¡ected will be the next challenge. For example, such knowledge could aid in treatment of the infection through enabling researchers to`push' the parasites in the direction of the less virulent bradyzoite or`pull' them back to the more drug-accessible tachyzoite stage. Four scenarios are shown (note that`no expression' could be due to insertion into a transcriptionally silent region, insertion in the wrong orientation, or insertion into the wrong frame or in any other way that fails to yield expression). The outcome of selection with 6-TX under tachyzoite growth conditions and MPA under bradyzoite conditions are shown (the large X indicates a block in growth; see text for explanation).
